Collection episode 02 · 2:10 · English
Peptides in 2TM · Humanin
Humanin: How a Tiny Peptide Helps Stressed Cells Survive
What helps a stressed cell survive? In 2001, researchers in Tokyo screened genetic material from the brain of a person with Alzheimer’s disease. They found a 24-amino-acid peptide that helped cultured nerve cells survive selected stresses. They called it Humanin.
The discovery led to experiments on Bax, a protein involved in programmed cell death, and later to studies of aging. Researchers engineered worms to make more Humanin, gave mice a modified form called HNG, and compared naturally occurring Humanin levels in people. Each study asked a different question. Follow the film, then look at what the researchers actually measured. Discovery paper · Bax experiments · Aging study
English narration with optional English captions.
Inside the film
Select a time to play from that point.
- The 2001 discovery at Keio University in Tokyo
- The original 24-amino-acid peptide and its connection to mitochondrial DNA
- What happened in cultured nerve cells
- How Humanin interfered with Bax in laboratory experiments
- Why the worm lifespan result and the mouse HNG result answer different questions
- What the researchers measured in people
- U.S. approval status and the question that remains
From discovery to evidence
2001–2002 · What Humanin is and how it was found
Yuichi Hashimoto, Ikuo Nishimoto, and colleagues at Keio University used a genetic screen in cultured cells to look for a factor that could help cells survive an Alzheimer’s-related stress. The screen used a library of DNA copies made from RNA in brain tissue from a person with Alzheimer’s disease. The researchers traced the protective effect to the sequence for a short peptide and named it Humanin.
The original report described a 24-amino-acid form. Its sequence is linked to a region of mitochondrial DNA associated with 16S ribosomal RNA. A follow-up paper investigated whether a Humanin-like peptide is produced in living tissue. In the original cell experiments, Humanin helped against selected insults, including exposure to amyloid beta. The measured outcome was survival of cultured cells under those conditions. Whether a treatment could improve memory or slow Alzheimer’s disease in patients would require a human study measuring those outcomes. Hashimoto and colleagues, 2001 · Tajima and colleagues, 2002
2003 · What the Bax experiments showed
Bax helps initiate apoptosis, a form of programmed cell death. When activated, Bax can move to the outer mitochondrial membrane and contribute to the release of cytochrome c, which helps activate the cell’s death machinery. Bin Guo and colleagues at the Burnham Institute found that Humanin bound Bax and interfered with its movement to mitochondria in their experiments. That interaction is the step shown in the film.
Other cell experiments explored signaling through a receptor complex involving CNTFRα, WSX-1, and gp130. These studies examined different ways Humanin could affect cell survival under particular conditions. Their relevance depends on the model, the peptide form, and the outcome measured. Guo and colleagues, 2003 · Hashimoto and colleagues, 2009
2020 · Three experiments, three kinds of evidence
| Study | What researchers did | What they found | How to read it |
|---|---|---|---|
| Worm lifespan | What researchers didCompared genetically engineered C. elegans that produced more Humanin with wild-type worms. | What they foundMean lifespan was 19.0 days versus 17.7 days in the reported comparison. | How to read itThe experiment tested genetic overexpression in worms. The result applies to that model and intervention. Figure 1 |
| Mouse body composition and lifespan | What researchers didCompared female mice given HNG, a Humanin analogue with glycine substituted for serine at position 14, with controls. Body composition was measured by micro-CT in five animals per group. | What they foundThe HNG group had less visceral fat and more lean mass. The lifespan comparison showed no statistically significant difference. | How to read itThe imaging outcomes describe body composition. The experiment used a modified peptide in mice, and its lifespan outcome was assessed separately. Figure 3 |
| Human blood measurements | What researchers didCompared circulating Humanin in 18 adult children of centenarians and 19 age-matched controls. | What they foundThe adult children of centenarians had higher circulating levels in this sample. | How to read itThe study measured Humanin already present in participants. It leaves open whether those levels influenced longevity and what would happen if a peptide were given as a treatment. Figure 5 |
Human evidence, safety, and U.S. status
Humanin appears in human studies as a substance that researchers measure. For example, a registered study examines plasma Humanin in acute kidney injury. In that setting, the research question is whether the measurement has clinical value. The seven records returned by a ClinicalTrials.gov search for “Humanin” contained no intervention that administered Humanin. That result describes the records found by this query. ClinicalTrials.gov search · Acute kidney injury study record
A Drugs@FDA active-ingredient search found no approved product containing Humanin. The research featured here leaves human treatment benefit and long-term safety unresolved. Drugs@FDA data query
What would move the evidence forward?
- Peptide identity. Confirm the sequence and preparation in each experiment so findings for native Humanin, HNG, and shorter fragments can be interpreted separately.
- Human measurements. Test whether circulating Humanin associations reproduce in larger, independent groups with consistent measurement methods and defined outcomes.
- Human treatment evidence. For any candidate that advances to clinical testing, specify the preparation, population, comparison group, and clinical outcome. A change in a blood marker and a change in how people feel, function, or survive answer different questions.
The Foundation’s Humanin research profile carries the broader evidence atlas, including work beyond the film’s scope. Humanin scientific record
The complete English transcript
A tiny peptide found in a brain-tissue screen raised a big question: what helps a cell survive when it comes under stress?
In 2001, Yuichi Hashimoto, Ikuo Nishimoto and colleagues at Keio University in Tokyo screened genetic material from a brain affected by Alzheimer's disease. They identified humanin, a peptide first described as a chain of twenty-four amino acids. Its sequence links it to mitochondrial DNA. A quarter century later, researchers are still following that clue.
In the original experiments, humanin helped cultured nerve cells survive certain insults tied to Alzheimer's disease. A later team found one way it could work. When a cell is pushed toward programmed death, a protein called Bax can move to the outer mitochondrial membrane. In lab experiments, humanin bound Bax and interfered with that move, interrupting a step in the cell's death pathway.
Then came an aging study. In 2020, worms engineered to make more humanin lived longer. In the same report, middle-aged mice given a modified version called H N G had less visceral fat and more lean mass, with no significant change in lifespan.
The researchers also found higher circulating humanin in adult children of centenarians than in age-matched controls. That was a comparison of naturally occurring levels. It did not test whether giving humanin changes how people age.
Humanin has no U.S. FDA approval. Its discovery still gives scientists a way to ask how mitochondria help decide whether a stressed cell survives.
World Peptide Foundation. Peptides in 2. Every experience matters.
Original sources & further reading
- Hashimoto and colleagues · Discovery and cultured-cell experiments · PNAS · 2001 · PMID 11371646
- Tajima and colleagues · Evidence of Humanin production in vivo · Neuroscience Letters · 2002 · PMID 12009529
- Guo and colleagues · Bax and programmed cell death · Nature · 2003 · PMID 12732850
- Hashimoto and colleagues · Humanin and cytokine-receptor signaling in cell experiments · Molecular Biology of the Cell · 2009 · PMID 19386761
- Yen and colleagues · Worm, mouse, and human findings · Aging · 2020 · PMID 32575074
- ClinicalTrials.gov · Humanin registry search
- FDA · How Drugs@FDA covers approved products
Synthetic-content disclosure
This episode uses synthetic narration and original illustrations of laboratory scenes, cells, and tissues. The Bax animation is a schematic of the experimental mechanism. The laboratory scenes illustrate the setting and processes described in the film.